Spyre Therapeutics (SYRE) FCF Margin (2015 - 2023)

Spyre Therapeutics posted quarterly FCF Margin of 2419.04% for Q2 2023, up 88864.0% year-on-year from N/an in Q2 2022, and up 72.84% on a QoQ basis from 8906.06% in Q1 2023.

Spyre Therapeutics (SYRE) has 7 years of FCF Margin data on file, last reported at 2419.04% in Q2 2023.

  • For the quarter ending Q2 2023, FCF Margin rose 88864.0% year-over-year to 2419.04%; the trailing twelve-month figure through Mar 2024 stood at 15806.83% (down 966812.0% YoY), and the FY2023 full-year result was 11276.52%, down 783376.0% from the prior year.
  • FCF Margin for Q2 2023 stood at 2419.04%, up from 8906.06% in the prior quarter.
  • Across five years, FCF Margin topped out at 20.91% in Q2 2021 and bottomed at 10797.62% in Q4 2022.
  • The 3-year median for FCF Margin is 2419.04% (2023), against an average of 4075.09%.
  • The widest annual swing landed in 2022, when FCF Margin slumped 1026886 bps; it then jumped 88864 bps in 2023.
  • A 3-year view of FCF Margin shows it stood at 528.76% in 2021, then tumbled by 1942 bps to 10797.62% in 2022, then surged by 78 bps to 2419.04% in 2023.
  • The last three FCF Margin figures came in at 2419.04% (Q2 2023), 8906.06% (Q1 2023), and 10797.62% (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 43.35%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.17%
10 Spyre Therapeutics 5.55 Bn 5.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 -2,419.04%
Mar 31, 2023 -8,906.06%
Dec 31, 2022 -10,797.62%
Sep 30, 2022 -8,660.34%
Jun 30, 2022 -3,307.68%
Mar 31, 2022 -1,930.98%
Dec 31, 2021 -528.76%
Sep 30, 2021 -146.25%
Jun 30, 2021 20.91%
Jun 30, 2018 -381.79%
Mar 31, 2018 -498.68%
Dec 31, 2017 -371.00%
Sep 30, 2017 -593.10%
Jun 30, 2017 -404.87%
Mar 31, 2017 -580.75%
Dec 31, 2016 -358.94%
Sep 30, 2016 -510.44%
Jun 30, 2016 -343.85%
Mar 31, 2016 -464.49%
Dec 31, 2015 -55.08%
Sep 30, 2015 -364.31%
Jun 30, 2015 -112.66%